Skip to main content
Genscript Biotech Corporation logo

Genscript Biotech Corporation — Investor Relations & Filings

Ticker · 1548 ISIN · KYG3825B1059 LEI · 529900YIYUOJOXSAE372 HKEX Manufacturing
Open in API
Filings indexed 819 across all filing types
Latest filing 2026-04-14 Earnings Release
Country KY Cayman Islands
Listing HKEX 1548

About Genscript Biotech Corporation

http://www.genscript.com/investor-relat…

Genscript Biotech Corporation is a world-leading technology and service provider specializing in life science research and manufacturing. The company offers a comprehensive portfolio of services and products essential for fundamental life science research, translational biomedical research, and early drug discovery and development. Core offerings include custom synthesis of genes, peptides, proteins, and antibodies, alongside molecular cloning and oligonucleotide production. GenScript also provides Contract Development and Manufacturing Organization (CDMO) solutions for innovative therapies through its specialized subsidiaries. The corporation leverages biotechnology and AI-driven approaches to advance life science solutions.

Recent filings

Filing Released Lang Actions
VOLUNTARY ANNOUNCEMENT: LEGEND ANNOUNCES PRELIMINARY SALES FOR CARVYKTI FOR THE QUARTER ENDED 31 MARCH 2026
Earnings Release Classification · 1% confidence The document is a voluntary announcement by Genscript Biotech Corporation providing preliminary sales figures for CARVYKTI® for the quarter ended 31 March 2026. It does not represent a full interim (IR) or annual report (10-K or IR), nor is it a governance or board management change notice. It is an initial financial update with key highlights for a quarterly period, matching the definition of an Earnings Release (ER). Q1 2026
2026-04-14 English
FORM OF PROXY FOR 2026 ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a Form of Proxy for the 2026 Annual General Meeting, providing voting instructions and solicitation materials to shareholders to appoint proxies and vote on resolutions at the AGM. This matches the definition of Proxy Solicitation & Information Statement.
2026-04-13 English
PROPOSALS FOR (1) GRANTING OF GENERAL MANDATES TO ISSUE NEW SHARES AND TO BUY BACK SHARES; (2) RE-ELECTION OF RETIRING DIRECTORS; (3) AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a circular sent to shareholders in advance of the company’s Annual General Meeting. It contains the notice of meeting, detailed explanatory statements for resolutions (issuance mandates, buy-back mandates, re-election of directors, amendments to constitutional documents), and a proxy form. This matches a Proxy Solicitation & Information Statement rather than the AGM presentation itself or the full annual report. Therefore, it is classified as PSI.
2026-04-13 English
NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 1% confidence The document is the formal notice convening Genscript Biotech Corporation’s 2026 Annual General Meeting, detailing the date, time, venue, resolutions to be voted on and proxy appointment instructions. It is sent to shareholders to request attendance and proxy votes, rather than the report itself or the meeting outcomes. This aligns with Proxy Solicitation & Information Statement (PSI).
2026-04-13 English
2025 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
Environmental & Social Information Classification · 1% confidence The document is clearly titled “Environmental, Social and Governance Report” and provides detailed ESG performance data, structure, governance, UN SDGs alignment, stakeholder engagement processes, and quantitative ESG KPIs for the 2025 reporting period. It is a standalone sustainability report, not an annual financial report, earnings release, or investor presentation. This matches the definition of Environmental & Social Information (Code: SR).
2026-04-13 English
2025 Annual Report
Regulatory Filings
2026-04-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.